Atlas Trials

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

Clinical trial NCT02473328 · COMPLETED

Trial details

NCT number
NCT02473328
Sponsor
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2015-06-01
Primary completion
2017-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.